Ask AI
Laura Spring

Laura Spring, MD

Breast Medical Oncologist
Mass General Hospital Cancer Center
Harvard Medical School
Boston, Massachusetts

Explore Activities by Laura Spring

Title
Format
Credit Type
Credits
Thoughts on the Evolving Treatment Options for First-line Management of HER2-Positive mBC

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Takeaways From a Large Educational Program on Available and Emerging Treatment Options for HER2-Positive mBC

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Interactive Decision Support Tool: Expert Treatment Guidance for HER2-Positive Metastatic Breast Cancer

Content Format:

Tool

Credit Type:

--

Credits:

--
Test Your Skills: Management of a Patient With HR-Positive/HER2-Positive mBC Progressing on Adjuvant Therapy

Content Format:

Case Challenge

Credit Type:

AAPA | ABIM MOC | ACPE | AMA | ANCC

Credits:

0.50
Management of a Patient With Newly Diagnosed HR+/HER2+ mBC on Medication for Comorbidities

Content Format:

Case Challenge

Credit Type:

AAPA | ABIM MOC | ACPE | AMA | ANCC

Credits:

0.50
An Interactive Tool for Managing AEs With CDK4/6 Inhibitors for HR+, HER2– Breast Cancer

Content Format:

Tool

Credit Type:

--

Credits:

--
Oncologist On-Call: Thoughts on the Current Treatment Landscape for First-line Management of HER2-Positive mBC

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Navigating Your Journey With CDK4/6 Inhibitors: A Guide for Thriving During Treatment

Content Format:

PDF

Credit Type:

--

Credits:

--
Expert Insights and FAQs on CDK4/6 Inhibitors in the Care of Today’s Patients With HR-Positive/HER2-Negative Breast Cancer

Content Format:

Podcast Episodes

Credit Type:

ABIM MOC | AMA

Credits:

0.75
Individualizing the Current Adjuvant Therapy Algorithm for Patients With HR+/HER2- EBC

Content Format:

Video

Credit Type:

ABIM MOC | AMA

Credits:

0.50
Individualizing Therapy for Patients With HR+/HER2- MBC

Content Format:

Video

Credit Type:

ABIM MOC | AMA

Credits:

0.50
Managing AEs With CDK4/6 Inhibitors to Promote Adherence and Persistence to Oral Therapy in Your Practice

Content Format:

Video

Credit Type:

ABIM MOC | AMA

Credits:

0.50
Clinical Highlights: Oral SERDs for Patients With HR+/HER2- ESR1-Mutated Advanced Breast Cancer

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Estrogen Receptor Mutations in HR+ Breast Cancer: Next-Generation Practice Recommendations on Mutation Screening to Guide Therapeutic Decisions

Content Format:

Video

Credit Type:

ABIM MOC | AMA

Credits:

1.25
Improving Outcomes in Patients With High-risk Breast Cancer: Outcomes and Analysis From an Educational Program on HR+/HER2- Early and Metastatic Breast Cancer

Content Format:

PDF

Credit Type:

--

Credits:

--
Managing AEs With CDK4/6 Inhibitors to Promote Adherence and Persistence to Oral Therapy in Your Practice

Content Format:

Slideset

Credit Type:

ABIM MOC | AMA

Credits:

0.25
Managing AEs With Oral SERDs for Patients With HR+/HER2- Metastatic Breast Cancer

Content Format:

Slideset

Credit Type:

--

Credits:

--
Integrating Oral SERDs Into Treatment for Patients With HR-positive/HER2-negative Metastatic Breast Cancer and Current Rationale or Medical Need

Content Format:

Slideset

Credit Type:

--

Credits:

--
Discussing Newer Treatment Options and What to Expect With Patients With High-Risk HR+/HER2- Early Breast Cancer

Content Format:

Video

Credit Type:

AAPA | ABIM MOC | ACPE | AMA | ANCC

Credits:

0.25
Adjuvant Therapy for HER2-Negative Early Breast Cancer: Interactive Decision Support Tool

Content Format:

Tool

Credit Type:

--

Credits:

--
Expert Guidance on Treating HR+/HER2- Breast Cancer to Improve Outcomes

Content Format:

Video

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

1.00
Making Treatment Decisions for Metastatic Breast Cancer: An Interactive Decision Support Tool for Patients

Content Format:

Tool

Credit Type:

--

Credits:

--
Improving Outcomes in Patients With High-Risk Breast Cancer: Expert Guidance and Team Training for HR-Positive/HER2-Negative Disease

Content Format:

Slideset

Credit Type:

--

Credits:

--
Interactive Decision Support Tool: Expert Treatment Guidance for Metastatic Breast Cancer

Content Format:

Tool

Credit Type:

--

Credits:

--
As the Treatment of HER2-Negative Early Breast Cancer Evolves, So Does Our Corresponding Treatment Decision Support Tool

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
(Neo)Adjuvant Therapy in HER2-Negative Early Breast Cancer Treatment Selection Tool

Content Format:

Tool

Credit Type:

--

Credits:

--
Improving Outcomes in HER2-Negative Early Breast Cancer With Individualized Targeted Approaches

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Introducing Novel Agents Into the Armamentarium for Triple-Negative Breast Cancer

Content Format:

Video

Credit Type:

AAPA | ANCC

Credits:

1.00
Introducing Novel Agents Into the Armamentarium for Triple-Negative Breast Cancer

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
A 44-Year-Old Patient With Rapidly Progressing Metastatic TNBC Who Receives Sacituzumab Govitecan

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Latest Insights on Ki-67 Use in HR-Positive/HER2-Negative Early Breast Cancer

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
(Neo) Adjuvant Therapy in HER2-Negative Early Breast Cancer Treatment Selection Tool

Content Format:

Tool

Credit Type:

--

Credits:

--
Key Updates in the Treatment of Hormone Receptor–Positive Breast Cancer

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Expanding the Scope of Precision Care for Patients With HR-Positive Breast Cancers: Things You Should Know

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.50
Practical Management of Adverse Events and Strategies to Promote Adherence with Targeted Therapies in HR-Positive Breast Cancer

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
What to Know About the New Approval for Abemaciclib in Patients With Early Breast Cancer

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
An Interactive Tool for Managing AEs With Oral Targeted Therapies for HR+, HER2– Breast Cancer

Content Format:

Tool

Credit Type:

--

Credits:

--